|
 |
CASES FROM ACKERMAN ACADEMY |
|
Year : 2013 | Volume
: 4
| Issue : 3 | Page : 244-245 |
|
|
Dermpath Quiz
Johanna Durda1, Viktoryia Kazlouskaya2, Elen Blochin2, Ciara A Maguire2, Dirk Elston2
1 Department of Dermatology, Elbe Klinikum Buxtehude, Buxtehude, Germany; Ackerman Academy of Dermatopathology, New York, USA 2 Ackerman Academy of Dermatopathology, New York, USA
Date of Web Publication | 24-Jul-2013 |
Correspondence Address: Dirk Elston 145 East 32nd St 10th Floor, New York, USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2229-5178.115536
How to cite this article: Durda J, Kazlouskaya V, Blochin E, Maguire CA, Elston D. Dermpath Quiz. Indian Dermatol Online J 2013;4:244-5 |
A 35-year-old female patient with a several month history of a skin-colored nodule on the toe presented to the dermatology clinic. Clinically, the lesion was suggestive of a fibroma.
Histopathological sections showed a dermal tumor composed of stellate and spindle-shaped cells with fasciculated growth between collagen bundles and a myxoid stroma [Figure 1] and [Figure 2]. The deep portion of the lesion demonstrated a nodular growth pattern with some infiltration of surrounding collagen, myxoid stroma and mast cells. Immunohistochemical stains demonstrated diffuse strong expression of CD34 [Figure 3] and focal positivity for CD 99. Only scattered Factor XIIIa cells were present. S100 and EMA were negative. | Figure 2: Fasciculated growth of spindle cells between collagen bundles in the superficial portion of the lesion. [H & E, ×400]
Click here to view |
The tumor most likely represents:
- Acquired digital fibrokeratoma
- Periungual fibroma
- Digital fibromyxoma
- Neurofibroma
- Inclusion body fibroma
View Answer
Answer: C. Digital fibromyxoma Discussion | |  |
Presence of a nodular dermal component with mucinous stroma, spindle- or stellate-shaped cells within a loose myxoid stroma, focal infiltration of the dermis and positivity with CD34 all serve as clues to the diagnosis of digital fibromyxoma (superficial acral fibromyxoma). Digital fibromyxoma is a benign soft tissue tumor with a nodular myxoid or cellular component and a predilection for acral sites. It typically has a loose storiform and fascicular growth pattern and the cells are surrounded by a myxoid or collagenous stroma. The tumor itself has a striking predilection for the fingers and toes, but occurrence on other portions of the hands and feet including the heel has been reported. [1] Nuclear atypia and mitotic figures are rarely seen. But multinucleate stromal cells are occasionally noted. [2] The superficial portion of the tumor can resemble acquired digital fibrokeratoma, but in contrast to acquired digital fibrokeratomas and periungual fibromas, there is a deep nodular component, typically with infiltration of surrounding collagen. In addition, digital fibromyxoma has a less tendency for concentric perivascular fibrosis and vertical streaking of collagen, especially in the deeper component [Figure 3]. In digital fibromyxomas, an overlying keratin horn and collarette are typically lacking, Factor XIIIa is negative or only focally positive, and EMA can sometimes be expressed focally. Unlike periungual fibromas, there is no association with tuberous sclerosis. Unlike neurofibroma, S100 is negative or only weakly positive. Digital fibromyxomas lack the intersecting fascicles and SMA+ cytoplasmic inclusion bodies found in inclusion body fibroma (recurrent infantile digital fibroma). Digital fibromyxoma was first described by Fetsch et al. in 2001 as superficial acral fibromyxoma. [3] Prescott et al, reviewed a series of 771 tumors from acral sites diagnosed between 1970 and 2006. Forty-one cases were reclassified as digital fibromyxoma, suggesting that the tumor is frequently misclassified. [4] This neoplasm can present at a wide range of ages (from 4 to 91), but most patients are middle-aged with some male predominance. The size of the lesion ranges from 0.5 to 5.0 cm. Dermal infiltration is common, but bone invasion is rare. [5],[6] Simple excision is usually adequate for recurrent tumors and malignant degeneration has not been reported, but recurrence after excision has been reported in up to 24% of cases.
References | |  |
1. | Al-Daraji WI, Miettinen M. Superficial acral fibromyxoma: A clinicopathological analysis of 32 tumors including 4 in the heel. J Cutan Pathol 2008;35:1020-6.  [PUBMED] |
2. | Hollmann TJ, Bovée JV, Fletcher CD. Digital fibromyxoma (superficial acral fibromyxoma): A detailed characterization of 124 cases. Am J Surg Pathol 2012;36:789-98.  |
3. | Fetsch JF, Laskin WB, Miettinen M. Superficial acral fibromyxoma: A clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Hum Pathol 2001;32:704-14.  [PUBMED] |
4. | Prescott RJ, Husain EA, Abdellaoui A, Al-Mahmoud RM, Khan M, Salman WD, et al. Superficial acral fibromyxoma: A clinicopathological study of new 41 cases from the UK: Should myxoma (NOS) and fibroma (NOS) continue as part of 21st-century reporting? Br J Dermatol 2008;159:1315-21.  [PUBMED] |
5. | Fanti PA, Dika E, Piraccini BM, Infusino SD, Baraldi C, Misciali C. Superficial acral fibromyxoma: a clinicopathological and immunohistochemical analysis of 12 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. G Ital Dermatol Venereol 2011;146:283-7.  [PUBMED] |
6. | Ben Brahim E, Bouabdellah M, Khanchel F, Jouini R, Abdelmoula S, Chadli-Debbiche A. Superficial acral fibromyxoma. Tunis Med 2012;90:340-1.  [PUBMED] |
[Figure 1], [Figure 2], [Figure 3]
|